natgillin/translations-raw huggingface dataset:
Prometax kan påvirke antikolinerg medicin hvoraf noget er medicin, der bruges mod mavekramper eller spasmer (fx dicyclomin), til at behandle Parkinsons sygdom (fx amantadin) eller til at forebygge transportsyge (fx difenhydramin, scopolamin eller meclizin).
Prometax might interfere with anticholinergic medicines some of which are medicines used to relieve stomach cramps or spasms (e.g. dicyclomine), to treat Parkinson’s disease (e.g. amantadine) or to prevent motion sickness (e.g. diphenhydramine, scopolamine, or meclizine).
Prometax må heller ikke anvendes til patienter, hvor der er mistanke om, at der tidligere er forekommet en svær allergisk reaktion kaldet ‘allergisk kontaktdermatitis’ over for Prometax-depotplaster.
Prometax must also not be used in patients who are suspected to have had in the past a severe allergic reaction called ‘allergic contact dermatitis’ to Prometax patch.
Prometax må ikke bruges under graviditet, medmindre det er strengt nødvendigt.
Prometax should not be used during pregnancy unless clearly necessary.
Prometax må ikke tages under graviditet, medmindre det er strengt nødvendigt.
Prometax should not be used during pregnancy unless clearly necessary.
Prometax oral opløsning leveres som 50 ml eller 120 ml klar gul opløsning (2,0 mg/ml base) i en brun glasflaske med børnesikret låg med tætningsindsats, isat rør med holder, hvori doseringssprøjten fastgøres.
Prometax oral solution is supplied as 50 ml or 120 ml of a clear, yellow solution (2.0 mg/ml base) in an amber glass bottle with a child-resistant cap, foam liner, dip tube and self aligning plug.
Prometax oral opløsning skal anvendes inden 1 måned efter, at flasken er åbnet.
Use Prometax oral solution within 1 month of opening the bottle.
Prometax rivastigmin
Prometax rivastigmine
Prometax-kapsler blev desuden undersøgt hos 541 patienter med demens som følge af Parkinsons sygdom.
Prometax capsules have also been studied in 541 patients with dementia due to Parkinson’s disease.
Prometaxs udseende og pakningsstørrelser
What Prometax looks like and contents of the pack
Prometaxs udseende og pakningstørrelser
What Prometax looks like and contents of the pack
Prompte medicinsk behandling af diarré skal iværksættes for at undgå dehydrering.
Prompt medical management of diarrhoea should be instituted in order to prevent dehydration.
prop
aluminium
prop
closure and
Prop: brombutyl-gummiprop
Stoppers: Bromobutyl rubber stoppers
Propafenon har negative inotropiske og betablokerende egenskaber, som kan have en forstærkende virkning på propranolols egenskaber, på trods af et betryggende studie med raske frivillige.
Propafenone has negative inotropic and beta-blocking properties that can be additive to those of propranolol, despite a reassuring study in healthy volunteers.
Propiedades farmacocinéticas
Pharmacokinetic properties
Propiedades farmacodinámicas
Pharmacodynamic properties
PROPIEDADES FARMACOLÓGICAS
PHARMACOLOGICAL PROPERTIES
Proportional reporting ratio (PRR), Information Component (IC) eller Empirical Bayesion Geometric Mean (EBMG)); dette er ikke et påbud, idet ikke alle indehavere af en markedsføringstilladelse har denne kapacitet.
Proportional reporting ratio (PRR), Information Component (IC) or the Empirical Bayesian Geometric Mean (EBMG)); this is not mandatory as all MAHs do not yet have this capability.
Proportionale stigninger i plasmakoncentrationen sås for doser fra 2 - 60 mg.
Proportional increases of the plasma concentration were observed for doses from 2-60 mg.
Proportionale stigninger i plasmakoncentrationen sås for doser fra 2 - 60 mg.
Proportional increases of the plasma concentration were observed for doses from 2–60 mg.
Proportionale stigninger i plasmakoncentrationen sås for doser fra 2-60 mg.
Proportional increases of the plasma concentration were observed for doses from 2 – 60 mg.
Proportionale stigninger i plasmakoncentrationen sås for doser fra 2-60 mg.
Proportional increases of the plasma concentration were observed for doses from 2-60 mg.
Proportionale stigninger i plasmakoncentrationen sås for doser fra 2-60 mg.
Proportional increases of the plasma concentration were observed for doses from 2–60 mg.
Proportionale stigninger i serumkoncentrationen sås for doser fra 2 til 60 mg.
Proportional increases of the serum concentration were observed for doses from 2-60 mg.
Proppen må højst perforeres 50 gange.
Do not broach the stopper more than 50 times.
Propper i ørerne*
Ear congestion
Propranolol metaboliseres gennem tre primære ruter: aromatisk hydroxylation (hovedsagelig 4- hydroxylation), N-dealkylation efterfulgt af yderligere sidekæde-oxidation og direkte glukuronidation.
Propranolol is metabolized through three primary routes: aromatic hydroxylation (mainly 4- hydroxylation), N-dealkylation followed by further side-chain oxidation, and direct glucuronidation.
Propulsiva
Propulsive
Propylenglycol (E1520)
Propylene Glycol (E1520)
Propylenglycol (E1520) Indigotin I (E 132)
Propylene glycol (E1520)
Propylenglycol Ammoniumhydroxid 28 %
Propylene glycol Ammonium hydroxide 28
Propylenglycol Glycerol
Propylene glycol Glycerol
Propylenglycol kan forårsage irritation.
Propylene glycol may cause irritation.
Propylenglycol Renset vand Kaliumhydroxid Jernoxid (E172)
Propylene Glycol Purified Water Potassium Hydroxide Iron Oxide (E172)
propylenglycol, der kan give irritation af huden.
Propylene glycol which may cause skin irritation.
propylenglycol, renset vand, ammoniumhydroxid, kaliumhydroxid, sort jernoxid (E 172).
Printing ink: shellac, propylene glycol, purified water, ammonium hydroxide, potassium hydroxide, black iron oxide (E 172).
propylenglycol: som kan give hudirritation.
propylene glycol: May cause skin irritation.
Propylenglycolmonomethylether (Dowanol PM)
Propylene glycol monomethyl ether (Dowanol PM)
Propylenglykol5
Propylene glycol5
Propylenglykolalginat Citronflødesmag Natriumchlorid Sucralose
Propylene glycol alginate Citrus Cream flavour Sodium Chloride Sucralose
Propylgallat (E310)
Propyl gallate (E310)
Propylparahydroxybenzoat (E 216) 0,2 mg/ml Se afsnit 6.1 for en fuldstændig fortegnelse over hjælpestoffer
For the full list of excipients, see section 6.1
Propylparahydroxybenzoat (E 216) Ammoniumglycyrrhizat
Methyl parahydroxybenzoate (E218) Propyl parahydroxybenzoate (E216) Ammonium glycyrrhizate
Propylparahydroxybenzoat 0,2 mg Klar, farveløs injektionsvæske
Propyl parahydroxybenzoate 0.2 mg Clear, colourless solution for injection.
Propylparahydroxybenzoat 0,2 mg Klar, farveløs injektionsvæske, opløsning.
Propyl parahydroxybenzoate 0.2 mg Clear, colourless solution for injection.
ProQuad - Pulver i hætteglas og solvens i forfyldt injektionssprøjte med 1 separat kanyle - Pakning med 1, 10 eller 20 stk.
ProQuad - Powder in vial and solvent in pre-filled syringe with 1 unattached needle - Pack of 1, 10, 20
ProQuad - Pulver i hætteglas og solvens i forfyldt injektionssprøjte med 2 separate kanyler - - Pakning med 1, 10 eller 20 stk.
ProQuad - Powder in vial and solvent in pre-filled syringe with 2 unattached needles - Pack of 1, 10, 20
ProQuad - Pulver i hætteglas og solvens i forfyldt injektionssprøjte med påhæftet kanyle- Pakning med 1 stk., 10 stk.
ProQuad - Powder in vial and solvent in pre-filled syringe with attached needle - Pack of 1, 10
ProQuad blev sammenlignet med de vacciner, den er sammensat af, nemlig en tredobbelt vaccine mod fåresyge, mæslinger og røde hunde og en vaccine mod skoldkopper.
ProQuad was compared with its ‘component vaccines’, a triple vaccine against mumps, measles and rubella, and a vaccine against chickenpox.
ProQuad bør ikke gives til gravide kvinder.
ProQuad should not be given to pregnant women .
ProQuad fås i pakninger med 1 stk. og pakninger med 10 stk.
ProQuad is available in pack of 1 and pack of 10.
ProQuad fås i pakninger med 1, 10 eller 20 stk.
ProQuad is available in pack of 1, 10 and 20.
ProQuad indeholder sorbitol
ProQuad contains sorbitol
ProQuad kan gives samtidigt med andre børnevacciner som Prevenar og/ eller hepatitis A vaccine, eller vacciner mod difteri, stivkrampe, kighoste (acellulær), Haemophilus influenzae type b, polio (inaktiveret) eller hepatitis B. Vaccinerne skal gives på forskellige injektionssteder
ProQuad can be given at the same time as other childhood vaccines such as Prevenar, and/or hepatitis A vaccine, or with vaccines containing diphtheria, tetanus, acellular pertussis, Haemophilus influenzae type b, inactivated poliomyelitis, or hepatitis B. A different place for the injection will be used for each vaccine.
ProQuad kan indgives fra 9-måneders alderen.
ProQuad may be administered from 9 months of age.
ProQuad pulver og solvens til injektionsvæske, suspension
ProQuad powder and solvent for suspension for injection
ProQuad pulver og solvens til injektionsvæske, suspension i forfyldt injektionssprøjte Levende vaccine mod mæslinger, fåresyge, røde hunde og skoldkopper.
ProQuad powder and solvent for suspension for injection in a pre-filled syringe Measles, mumps, rubella and varicella vaccine (live).
ProQuad skal gives som indsprøjtning i en muskel eller under huden enten på yderlåret eller på overarmen.
ProQuad should be injected into the muscle or under the skin either in the area of the outer thigh or of the upper arm.
PROSPECTO
PACKAGE LEAFLET
prospecto: información para el usuario
Package leaflet: information for the user
Prostacyklinlignende relaterede bivirkninger
Prostacyclin-like associated adverse reactions
prostaglandiner er stoffer, der udløser en betændelsesreaktion, mindsker tepoxalin den betændelse og hævelse af muskler og led og den smerte, som de bevirker.
prostaglandins are substances that trigger inflammation, tepoxalin reduces the inflammation and the swelling of muscles or joints and the pain associated with this.
Prostatacancer
Prostate cancer
Prostatakræft
Prostate cancer
Prostatakræft har brug for testosteron og andre mandlige hormoner for at overleve og vokse og ved at blokere disse hormoner bremser enzalutamid væksten af prostatakræften.
Because prostate cancer needs testosterone and other male hormones to survive and grow, by blocking these hormones, enzalutamide slows down the growth of the prostate cancer.
prostatakræft i kombination med prednison eller prednisolon.
prostate cancer, with prednisone or prednisolone
Protamindosen afhænger af den administrerede dosis enoxaparin: 1 mg protaminsulfat neutraliserer den antikoagulerende aktivitet af 1 mg enoxaparinnatrium, hvis enoxaparinnatrium blev administreret inden for de seneste 8 timer.
The dose of Protamine depends on the dose of enoxaparin given; 1 mg of protamine sulphate neutralises the anticoagulant activity of 1 mg of enoxaparin sodium if enoxaparin sodium was administered during the last 8 hours.
Protamindosis afhænger af den administrerede dosis enoxaparin: 1 mg protaminsulfat neutraliserer den antikoagulerende aktivitet af 1 mg enoxaparinnatrium, hvis enoxaparinnatrium blev administreret inden for de seneste 8 timer.
The dose of Protamine depends on the dose of enoxaparin given; 1 mg of protamine sulphate neutralises the anticoagulant activity of 1 mg of enoxaparin sodium if enoxaparin sodium was administered during the last 8 hours.
Protaminsulfat m-cresol (1,76 mg/ml)
Protamine sulphate m-cresol [1.76 mg/ml]
Protaminsulfat m-cresol (2,20 mg/ml)
Protamine sulphate m-cresol [2.20 mg/ml]
Protaminsulfat og vitamin K forventes ikke at påvirke rivaroxabans antikoagulerende aktivitet.
Protamine sulfate and vitamin K are not expected to affect the anticoagulant activity of rivaroxaban.
Protaminsulfat Zinkoxid Glycerol
Protamine sulfate Zinc oxide Glycerol
Protaphane 100 internationale enheder/ml injektionsvæske, suspension
Protaphane 100 international units/ml Suspension for injection
Protaphane 100 internationale enheder/ml injektionsvæske, suspension i et hætteglas humant insulin
Protaphane 100 international units/ml suspension for injection in vial human insulin
Protaphane 100 internationale enheder/ml injektionsvæske, suspension.
Protaphane 100 international units/ml suspension for injection.
Protaphane 40 internationale enheder/ml Injektionsvæske, suspension
Protaphane 40 international units/ml Suspension for injection
Protaphane 40 internationale enheder/ml injektionsvæske, suspension i hætteglas humant insulin
Protaphane 40 international units/ml suspension for injection in vial human insulin
Protaphane 40 internationale enheder/ml injektionsvæske, suspension.
Protaphane 40 international units/ml suspension for injection.
Protaphane administreres subkutant ved injektion i låret abdominal væggen, gluteal- eller deltoidregionen.
Protaphane is administered subcutaneously by injection in the thigh, the abdominal wall, the gluteal region or the deltoid region.
Protaphane er en isophan humant insulin suspension (NPH).
Protaphane is an isophane (NPH) human insulin suspension.
Protaphane er et humant insulin med gradvist indsættende effekt og lang virkningsvarighed.
Protaphane is a human insulin with a gradual onset and long duration of action.
Protaphane er stort set natriumfrit.
Protaphane is essentially ‘sodium-free’.
Protaphane FlexPen 100 internationale enheder/ml Injektionsvæske, suspension
Protaphane FlexPen 100 international units/ml Suspension for injection
Protaphane FlexPen 100 internationale enheder/ml injektionsvæske, suspension i en fyldt pen humant insulin
Protaphane FlexPen 100 international units/ml suspension for injection in pre-filled pen human insulin
Protaphane FlexPen 100 internationale enheder/ml injektionsvæske, suspension i en fyldt pen.
Protaphane FlexPen 100 international units/ml suspension for injection in pre-filled pen.
Protaphane FlexPen er en fyldt pen beregnet til anvendelse sammen med NovoFine eller NovoTwist engangsnåle med en længde på op til 8 mm.
Protaphane FlexPen is a pre-filled pen designed to be used with NovoFine or NovoTwist disposable needles up to a length of 8 mm.
Protaphane FlexPen er forsynet med en indlægsseddel med detaljeret brugervejledning, som skal følges.
Protaphane FlexPen is accompanied by a package leaflet with detailed instructions for use to be followed.
Protaphane hætteglas er beregnet til anvendelse med insulin-injektionssprøjter, der har en passende enhedsskala.
Protaphane vials are for use with insulin syringes with a corresponding unit scale.
Protaphane hætteglas er beregnet til anvendelse sammen med insulin-injektionssprøjter, der har en passende enhedsskala.
Protaphane vials are for use with insulin syringes with a corresponding unit scale.
Protaphane hætteglas er forsynet med en indlægsseddel med detaljeret brugervejledning, som skal følges.
Protaphane vial is accompanied by a package leaflet with detailed instructions for use to be followed.
Protaphane i hætteglas skal bruges med insulin sprøjter med tilsvarende enhedsskala.
Protaphane vials are for use with insulin syringes with the corresponding unit scale.
Protaphane indeholder insulin blandet med et andet stof, protamin, i en form, der kaldes "isofan", som optages langsommere dagen igennem.
Protaphane contains insulin mixed with another substance, protamine, in an ‘isophane’ form which is absorbed much more slowly during the day.
Protaphane indeholder mindre end 1 mmol natrium (23 mg) per dosis, dvs.
Protaphane contains less than 1 mmol sodium (23 mg) per dose, i.e.
PROTAPHANE injektionsvæske, suspension i fyldt pen.
PROTAPHANE suspension for injection in pre-filled pen.
Protaphane InnoLet 100 internationale enheder/ml Injektionsvæske, suspension
Protaphane InnoLet 100 international units/ml Suspension for injection
Protaphane InnoLet 100 internationale enheder/ml injektionsvæske, suspension i en fyldt pen humant insulin
Protaphane InnoLet 100 international units/ml suspension for injection in pre-filled pen human insulin
Protaphane InnoLet 100 internationale enheder/ml Injektionsvæske, suspension i en fyldt pen Humant insulin
Protaphane InnoLet 100 international units/ml Suspension for injection in pre-filled pen Insulin human
Protaphane InnoLet 100 internationale enheder/ml injektionsvæske, suspension i en fyldt pen.
Protaphane InnoLet 100 international units/ml suspension for injection in pre-filled pen.
Protaphane Innolet er en fyldt pen beregnet til anvendelse sammen med NovoFine eller NovoTwist engangsnåle på op til 8 mm.
Protaphane InnoLet is a pre-filled pen designed to be used with NovoFine or NovoTwist disposable needles up to a length of 8 mm.
Protaphane InnoLet er forsynet med en indlægsseddel med detaljeret brugervejledning, som skal følges.
Protaphane InnoLet is accompanied by a package leaflet with detailed instructions for use to be followed.
Protaphane kan anvender til børn og unge.
Protaphane can be used in children and adolescents.
Protaphane kan anvendes under graviditet.
Protaphane can be used during pregnancy.
Protaphane Penfill 100 internationale enheder/ml Injektionsvæske, suspension
Protaphane Penfill 100 international units/ml Suspension for injection
Protaphane Penfill 100 internationale enheder/ml injektionsvæske, suspension i en cylinderampul humant insulin
Protaphane Penfill 100 international units/ml suspension for injection in cartridge human insulin
Protaphane Penfill er beregnet til anvendelse sammen med Novo Nordisk insulindispenseringssystemer og NovoFine eller NovoTwist engangsnåle.
Protaphane Penfill is designed to be used with Novo Nordisk insulin delivery systems and NovoFine or NovoTwist needles.
Protaphane Penfill er forsynet med en indlægsseddel med detaljeret brugervejledning, som skal følges.
Protaphane Penfill is accompanied by a package leaflet with detailed instructions for use to be followed.
Protaphane, som har været frossen, må ikke anvendes.
Protaphane which has been frozen must not be used.
proteaseaktivitet:
proteolytic activity:
proteasehæmmer (undtaget tipranavir/ritonavir, hvor dosis bør være 600 mg
dose should be 600 mg twice daily).
proteasehæmmer, som er en potent hæmmer
inhibitors that are potent inhibitors of
proteasehæmmer, som er en potent hæmmer
protease inhibitors that are potent
proteasehæmmer.
Concomitant use of
Proteasehæmmere
Protease inhibitors (PIs)
Proteasehæmmere (anvendes til behandling af HIV) atypiske antipsykotiske lægemidler (såsom olanzapin og clozapin).
thyroid hormones (used to treat the thyroid gland disorders), protease inhibitors (used to treat HIV), atypical antipsychotic medicines (such as olanzapine and clozapine).
Proteasehæmmere (anvendes til behandling af HIV), atypiske antipsykotiske lægemidler (såsom olanzapin og clozapin).
thyroid hormones (used to treat the thyroid gland disorders), protease inhibitors (used to treat HIV), atypical antipsychotic medicines (such as olanzapine and clozapine).
proteasehæmmere (f.eks. fosamprenavir, indinavir, ritonavir, saquinavir, tipranavir);
protease inhibitors (e.g. fosamprenavir, indinavir, ritonavir, saquinavir, tipranavir);
Proteasehæmmere (PI)
Protease inhibitors (PI)
Proteasehæmmere (PI)
Protease inhibitors (PIs)
Proteasehæmmere (PI)
Protease inhibitors (PIs):
Proteasehæmmere (PI) - boostede (med samtidig administration af lavdosis ritonavir)
Protease Inhibitors (PI) - Boosted (with co-administration of low-dose ritonavir)
Proteasehæmmere (PI) - med co-administration af lavdosis ritonavir †
HIV Protease inhibitors (PIs) - with co-administration of low dose ritonavir
Proteasehæmmere (PI) –uden yderligere co-administration af lavdosis ritonavir †
HIV Protease inhibitors (PIs) - without additional co-administration of low dose ritonavir
Proteasehæmmere (PI) –uden yderligere co-administration af lavdosis ritonavir †
low dose ritonavir, dose adjustment
Proteasehæmmere (PIer)
Protease inhibitors (PI)
Proteasehæmmere (PI’ere)
Protease inhibitors (PIs)
Proteasehæmmere - til behandling af HIV.
Protease inhibitors- for HIV.
proteasehæmmere peger på en mulig 3-4
protease inhibitors suggest a possible 3-4
proteasehæmmere, anti-infektionsmedicin såsom ketoconazol, svampemidler af azol- typen, clarithromycin eller telithromycin. carbamazepin, rifampicin, phenobarbital, phenytoin, efavirenz eller perikon (muligvis risiko for forringet virkning).
protease inhibitors, anti-infectives such as ketoconazole, azole antifungals, clarithromycin or telithromycin. carbamazepine, rifampicine, phenobarbital, phenytoin, efavirenz or St. John’s Wort (potential risk of reduced efficacy).
proteasehæmmere, der anvendes til behandling af HIV (human immundefekt virus)
protease inhibitors used in the treatment of Human Immunodeficiency Virus (HIV)
proteasehæmmere, se
HIV Protease Inhibitors (PIs)
Proteasehæmmere: EVOTAZ i kombination med andre proteasehæmmere frarådes, da samtidig administration muligvis ikke medfører tilstrækkelig protesehæmmer-eksponering.
Protease inhibitors: EVOTAZ in combination with other protease inhibitors is not recommended because co- administration may not provide adequate protease inhibitor exposure.
Proteasehæmmere: nøje monitorering for forekomst af lægemiddeltoksicitet og/eller mangel på antiviral effekt.
Protease inhibitors: careful monitoring for any occurrence of drug toxicity and /or lack of anti- viral efficacy, and dose
Proteaseinhibitorer, inklusive ritonavir og dets kombinationer med andre protease inhibitorer, påvirker P-gp (enten som inhibitor eller som induktor).
Protease inhibitors including ritonavir and its combinations with other protease inhibitors affect P-gp (either as inhibitor or as inducer).
Protein C er et vitamin K afhængigt antikoagulations glycoprotein, som er syntetiseret i leveren.
Protein C is a vitamin K-dependent anticoagulant glycoprotein which is synthesised in the liver.
Protein C, som er indeholdt i CEPROTIN, findes naturligt i humant plasma og virker som endogent protein C. Derfor anses eksperimentelle studier af tumorfremkaldende eller mutagene effekter - særligt hos heterologe arter – ikke for at være nødvendige.
Protein C contained in CEPROTIN is a normal constituent of human plasma and acts like endogenous protein C. Therefore experimental studies on tumorigenic or mutagenic effects - particularly in heterologous species - are not considered necessary.
Protein eller blod i urinen (ses ved en urinprøve).
Protein or blood in your urine (shown in a urine test).
Protein eller blod i urinen, galdesten, smertefuld vandladning
Protein or blood in the urine, gallstones, painful urination
Protein i urinen
Increased protein levels in urine
protein i urinen
protein in your urine
Protein i urinen (kan ses i en prøve)
Protein in urine (seen in tests)
Protein i urinen (konstateres ved en test)
Protein in the urine (found by testing)
Protein i urinen (også kaldet ‘proteinuri’): Meget almindeligt (kan påvirke mere end 1 ud af 10 personer) – dette er meget almindeligt at se i tests.
Protein in the urine (also called ‘proteinuria’): Very common (may affect more than 1 in 10 people) – this is very commonly seen in tests.
protein i urinen (proteinuri)
protein in the urine (proteinuria)
protein i urinen (proteinuri)
proteinuria,
Protein i urinen (ses i urinprøver)
Protein in the urine (may show in your urine tests)
Protein i urinen (ses ved en urintest)
Protein in your urine (shown in a urine test)
protein i urinen (unormale urinprøver)
protein in the urine (abnormal urine test)
protein i urinen forhøjet niveau af leverenzymer (ALAT, ASAT) i blodet
proteins (albumin) in urine increase in levels of liver enzymes (ALT, AST) in the blood
protein i urinen, efterfulgt af hævelser på kroppen,
presence of protein in your urine accompanied by swelling of your body,
protein i urinen, lejlighedsvis alvorligt og forbundet med bivirkninger som f.eks. oppustning
Protein in the urine, occasionally severe and associated with side effects, such as swelling
Proteinbinding af ceftiofur og dets hovedmetabolit er høj, cirka 70% – 90%.
Protein binding of ceftiofur and its major metabolite is high, approximately 70% – 90%.
Proteinbinding til humant serumprotein in vitro er  13%.
Protein binding to human serum protein in vitro is  13%.
Proteinbindingen af den hyppigst forekommende metabolit (para-hydroxy-sulfat) er meget høj ( 99,99 %).
The protein binding of the major metabolite (a para-hydroxy-sulphate) is very high (> 99.99%).
Proteinbindingen af den hyppigst forekommende metabolit (para-hydroxy-sulfat) er meget høj (99.99 %).
The protein binding of the major metabolite (a para-hydroxy-sulphate) is very high (> 99.99%).